185 related articles for article (PubMed ID: 1834329)
1. Predominance of the metastatic phenotype in somatic cell hybrids of the K-1735 murine melanoma.
Staroselsky AH; Pathak S; Chernajovsky Y; Tucker SL; Fidler IJ
Cancer Res; 1991 Dec; 51(23 Pt 1):6292-8. PubMed ID: 1834329
[TBL] [Abstract][Full Text] [Related]
2. Expression of collagenase IV (basement membrane collagenase) activity in murine tumor cell hybrids that differ in metastatic potential.
Turpeenniemi-Hujanen T; Thorgeirsson UP; Hart IR; Grant SS; Liotta LA
J Natl Cancer Inst; 1985 Jul; 75(1):99-103. PubMed ID: 2989606
[TBL] [Abstract][Full Text] [Related]
3. Direct correlation between DNA repair capacity and metastatic potential of K-1735 murine melanoma cells.
Wei Q; Cheng L; Xie K; Bucana CD; Dong Z
J Invest Dermatol; 1997 Jan; 108(1):3-6. PubMed ID: 8980277
[TBL] [Abstract][Full Text] [Related]
4. Metastatic potential of cloned murine melanoma cells transfected with activated c-Ha-ras.
Price JE; Aukerman SL; Ananthaswamy HN; McIntyre BW; Schackert G; Schackert HK; Fidler IJ
Cancer Res; 1989 Aug; 49(15):4274-81. PubMed ID: 2663141
[TBL] [Abstract][Full Text] [Related]
5. Predominance of the metastatic phenotype in hybrids formed by fusion of mouse and human melanoma clones.
van Golen KL; Risin S; Staroselsky A; Berger D; Tainsky MA; Pathak S; Price JE
Clin Exp Metastasis; 1996 Mar; 14(2):95-106. PubMed ID: 8605733
[TBL] [Abstract][Full Text] [Related]
6. Expression level of the nm23 gene in clonal populations of metastatic murine and human neoplasms.
Radinsky R; Weisberg HZ; Staroselsky AN; Fidler IJ
Cancer Res; 1992 Oct; 52(20):5808-14. PubMed ID: 1394207
[TBL] [Abstract][Full Text] [Related]
7. Transfection with the inducible nitric oxide synthase gene suppresses tumorigenicity and abrogates metastasis by K-1735 murine melanoma cells.
Xie K; Huang S; Dong Z; Juang SH; Gutman M; Xie QW; Nathan C; Fidler IJ
J Exp Med; 1995 Apr; 181(4):1333-43. PubMed ID: 7535333
[TBL] [Abstract][Full Text] [Related]
8. Metastatic phenotype in hybrid cells derived from B16 melanoma.
Ito M; Izuhara M; Shimizu K; Sekiguchi M
Cancer Lett; 1994 Apr; 78(1-3):33-9. PubMed ID: 8180966
[TBL] [Abstract][Full Text] [Related]
9. Increasing metastatic potential is associated with induced chromosome 14 translocations in a previously nonmetastatic murine melanoma cell line.
Nemeth MA; Wilson MR; Fidler IJ; Pathak S
Cancer Genet Cytogenet; 1997 Oct; 98(2):119-25. PubMed ID: 9332476
[TBL] [Abstract][Full Text] [Related]
10. Gene expression and metastasis of somatic cell hybrids between murine fibroblast cell lines of different malignant potential.
Tuck AB; Wilson SM; Sergovich FR; Chambers AF
Somat Cell Mol Genet; 1991 Jul; 17(4):377-89. PubMed ID: 1887334
[TBL] [Abstract][Full Text] [Related]
11. Metastatic phenotype of mouse-human melanoma cell hybrids is associated with the presence of chromosome 17 from highly metastatic human melanoma cells.
Risin S; Vangolen K; Price J; Pathak S
Int J Oncol; 1996 Aug; 9(2):225-34. PubMed ID: 21541504
[TBL] [Abstract][Full Text] [Related]
12. Immune response to somatic cell hybrids between ultraviolet radiation-induced regressor and spontaneous progressor C3H mouse tumor cells.
Chen PW; Kaba DS; Ananthaswamy HN
Cancer Res; 1990 Mar; 50(5):1544-9. PubMed ID: 2137370
[TBL] [Abstract][Full Text] [Related]
13. Inverse correlation between expression of inducible nitric oxide synthase activity and production of metastasis in K-1735 murine melanoma cells.
Dong Z; Staroselsky AH; Qi X; Xie K; Fidler IJ
Cancer Res; 1994 Feb; 54(3):789-93. PubMed ID: 7508336
[TBL] [Abstract][Full Text] [Related]
14. Multiple human chromosomes carrying tumor-suppressor functions for the mouse melanoma cell line B16-F10, identified by microcell-mediated chromosome transfer.
Kugoh H; Nakamoto H; Inoue J; Funaki K; Barrett JC; Oshimura M
Mol Carcinog; 2002 Nov; 35(3):148-56. PubMed ID: 12410566
[TBL] [Abstract][Full Text] [Related]
15. Melanoma x macrophage hybrids with enhanced metastatic potential.
Rachkovsky M; Sodi S; Chakraborty A; Avissar Y; Bolognia J; McNiff JM; Platt J; Bermudes D; Pawelek J
Clin Exp Metastasis; 1998 May; 16(4):299-312. PubMed ID: 9626809
[TBL] [Abstract][Full Text] [Related]
16. Evidence of a dominant transcriptional pathway which regulates an undifferentiated and complete metastatic phenotype.
Barsky SH; Sternlicht MD; Safarians S; Nguyen M; Chin K; Stewart SD; Hiti AL; Gray JW
Oncogene; 1997 Oct; 15(17):2077-91. PubMed ID: 9366525
[TBL] [Abstract][Full Text] [Related]
17. Specific chromosomal defects associated with metastatic potential in K-1735 melanoma clones. Involvement of chromosomes 4 and 14.
Pathak S; Staroselsky AN; Fidler IJ
Cancer Genet Cytogenet; 1991 Oct; 56(2):209-21. PubMed ID: 1756466
[TBL] [Abstract][Full Text] [Related]
18. Demonstration of multiple phenotypic diversity in a murine melanoma of recent origin.
Fidler IJ; Gruys E; Cifone MA; Barnes Z; Bucana C
J Natl Cancer Inst; 1981 Oct; 67(4):947-56. PubMed ID: 6944560
[TBL] [Abstract][Full Text] [Related]
19. Correlation of growth capacity of cells in hard agarose with successful transfection by the activated c-Ha-ras oncogene and in vivo proliferative capacity at metastatic sites.
Fidler IJ; Li LM; Ananthaswamy HN; Esumi N; Radinsky R; Price JE
Anticancer Res; 1991; 11(1):17-24. PubMed ID: 2018350
[TBL] [Abstract][Full Text] [Related]
20. Association in the expression of Kirsten-ras oncogene and the major histocompatibility complex class I antigens in fibrosarcoma tumor cell variants exhibiting different metastatic capabilities.
Alon Y; Hammerling GJ; Segal S; Bar-Eli M
Cancer Res; 1987 May; 47(10):2553-7. PubMed ID: 3552201
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
